IntrinsicIntrinsic
← Scroll for more →

Credicorp Ltd (BAP)

Business Summary

Credicorp Ltd. is a holding company that, through its subsidiaries, provides a wide range of financial services, including universal banking, microfinance, insurance and pension funds, and investment management and advisory services, primarily in Peru, but also in Bolivia, Colombia, Chile, and other countries. The industry is highly competitive, with competition based on brand recognition, product quality, price, and innovation.

In Universal Banking, Credicorp's main competitors in Peru include Banco BBVA Peru, Banco de la Nacion, Banco Santander Peru, Banco Interbank, Banco Pichincha, Scotiabank Peru, and Banco GNB. In Microfinance, competitors include Compartamos Financiera, Caja Arequipa, Caja Piura, Caja Huancayo, Caja Cusco, Caja Sullana, Caja Trujillo, Caja Ica, Caja Maynas, Caja Tacna, Caja Del Santa, Caja Paita, Caja Los Andes, Caja Rural de Ahorro y Credito, Financiera Confianza, Financiera Credinka, Financiera Efectiva, Financiera ProEmpresa, Financiera Oh!, and Financiera Qapaq. In Insurance & Pensions, competitors include Rimac Seguros, Mapfre Peru, Interseguro, La Positiva, and Protecta. In Investment Management and Advisory, competitors include Credibolsa, Kallpa Securities, Seminario & Cia, Inteligo, and Diviso Bolsa.

Credicorp generates revenue through a diversified business model encompassing net interest income from its banking and microfinance operations, insurance premiums and pension fund management fees, and fees from investment management and advisory services. The company serves a broad range of customer segments, from individuals and small businesses to large corporations, and operates through a multi-channel platform that includes physical branches, digital banking, and mobile applications.

The Universal Banking segment, primarily through Banco de Credito del Peru (BCP), offers a full range of banking products and services, including loans, deposits, and credit cards, to retail, small business, and corporate clients. The Microfinance segment, primarily through Mibanco, focuses on providing financial services to micro-entrepreneurs and small businesses in Peru and Colombia. The Insurance & Pensions segment, through Pacifico Seguros and Prima AFP, offers life and property/casualty insurance products and manages private pension fund accounts. The Investment Management and Advisory segment provides asset management, brokerage, and investment banking services through Credicorp Capital and other subsidiaries.

During the period, Credicorp completed the acquisition of Pacifico EPS, an entidad prestadora de salud (health services provider), for a total consideration of S/ 1,000 million . The company also issued subordinated bonds, including 6.45% Subordinated Fixed-to-Fixed Rate Notes for US$ 500 million and 5.65% Subordinated Fixed-to-Fixed Rate Notes for US$ 750 million . Additionally, Credicorp repurchased 347,064 common shares for US$ 60.0 million under its share repurchase program.

For the fiscal year ended December 31, 2025, Credicorp reported total revenues of S/ 23,486 million , compared to S/ 21,088 million in the prior year. Net income attributable to equity holders of the parent was S/ 4,556 million , up from S/ 4,074 million in 2024. Diluted earnings per share were S/ 48.27 , compared to S/ 42.78 in the prior year.

Business Outlook & Financial Sufficiency

A key growth vector is the expansion of digital financial services, particularly through Yape, a mobile payment platform. Yape had 16.0 million active users as of December 31, 2025, and processed transactions totaling S/ 107,000 million during the year. The company is also focused on growing its microfinance operations in Colombia through Mibanco Colombia, which had a gross loan portfolio of S/ 1,750 million as of December 31, 2025.

Another growth vector is the expansion of the insurance and pension business. Pacifico Seguros is focused on growing its market share in the property and casualty insurance market, while Prima AFP manages pension fund assets under management (AUM) of S/ 56,000 million as of December 31, 2025.

The filing discusses the evolution of the cost structure but does not provide specific margin or cost targets for the upcoming period.

The filing discusses technology investments but does not provide specific capital expenditure targets or headcount strategy for the upcoming period.

The filing does not provide specific R&D spending levels, capital expenditure plans, share repurchase authorization amounts, or dividend policy figures for the upcoming period.

A significant headwind is the macroeconomic and political environment in Peru, which could impact economic growth and credit demand. The filing notes that the Peruvian economy is sensitive to global commodity prices and political instability.

Another constraint is the regulatory environment, particularly in the insurance and pension sectors, where changes in regulations could affect profitability. The filing also notes that the company is subject to foreign exchange risk, as a portion of its assets and liabilities are denominated in U.S. dollars and other foreign currencies.

Management Sentiments & Priorities

Management's message emphasizes the company's strong financial performance in 2025, driven by growth across all business segments. The strategic priorities for the period ahead include deepening digital transformation, particularly through the Yape platform, expanding the microfinance business in Colombia, and integrating the recently acquired Pacifico EPS to create a more comprehensive healthcare offering. Management also highlights the importance of maintaining a strong capital position and managing risks effectively.

Financial Details

Total revenues for the fiscal year ended December 31, 2025, were S/ 23,486 million , compared to S/ 21,088 million in 2024. Net income attributable to equity holders of the parent was S/ 4,556 million in 2025, compared to S/ 4,074 million in 2024. Diluted earnings per share were S/ 48.27 in 2025, compared to S/ 42.78 in 2024. Operating income was S/ 6,643 million in 2025, compared to S/ 5,892 million in 2024. The return on average equity (ROE) was 17.3% in 2025, compared to 16.8% in 2024. Cash and cash equivalents were S/ 27,000 million as of December 31, 2025, compared to S/ 24,000 million as of December 31, 2024. Total assets were S/ 280,000 million as of December 31, 2025, compared to S/ 260,000 million as of December 31, 2024. The Universal Banking segment reported net income of S/ 3,500 million in 2025. The Microfinance segment reported net income of S/ 400 million in 2025. The Insurance & Pensions segment reported net income of S/ 700 million in 2025. The Investment Management and Advisory segment reported net income of S/ 100 million in 2025.

Risk Factors

A material risk is the company's exposure to the Peruvian economy, which is subject to political instability, social unrest, and fluctuations in commodity prices, all of which could adversely affect credit quality and demand for financial services. The company also faces significant credit risk, with a gross loan portfolio of S/ 180,000 million as of December 31, 2025, and non-performing loans (NPLs) of S/ 4,500 million , representing an NPL ratio of 2.5% . Another key risk is foreign exchange risk, as a portion of the loan portfolio and funding is denominated in U.S. dollars; a 10% devaluation of the Peruvian sol against the U.S. dollar would result in a loss of S/ 200 million in net income. The company is also exposed to regulatory risk, particularly in the insurance and pension sectors, where changes in regulations could impact profitability and capital requirements.

References

  1. [1] Item 4, Business Overview — Acquisition of Pacifico EPS
  2. [2] Item 5, Operating and Financial Review — Liquidity and Capital Resources
  3. [3] Item 5, Operating and Financial Review — Liquidity and Capital Resources
  4. [4] Item 5, Operating and Financial Review — Share Repurchase Program
  5. [5] Item 5, Operating and Financial Review — Share Repurchase Program
  6. [6] Item 5, Operating and Financial Review — Consolidated Results of Operations
  7. [7] Item 5, Operating and Financial Review — Consolidated Results of Operations
  8. [8] Item 5, Operating and Financial Review — Consolidated Results of Operations
  9. [9] Item 5, Operating and Financial Review — Consolidated Results of Operations
  10. [10] Item 8, Note 14 — Earnings Per Share
  11. [11] Item 8, Note 14 — Earnings Per Share
  12. [12] Item 4, Business Overview — Yape
  13. [13] Item 4, Business Overview — Yape
  14. [14] Item 4, Business Overview — Microfinance
  15. [15] Item 4, Business Overview — Insurance & Pensions
  16. [16] Item 4, Business Overview — Loan Portfolio
  17. [17] Item 4, Business Overview — Loan Portfolio
  18. [18] Item 4, Business Overview — Loan Portfolio
  19. [19] Item 11, Quantitative and Qualitative Disclosures About Risk Management — Currency Risk
  20. [20] Item 5, Operating and Financial Review — Consolidated Results of Operations
  21. [21] Item 5, Operating and Financial Review — Consolidated Results of Operations
  22. [22] Item 5, Operating and Financial Review — Consolidated Results of Operations
  23. [23] Item 5, Operating and Financial Review — Consolidated Results of Operations
  24. [24] Item 8, Note 14 — Earnings Per Share
  25. [25] Item 8, Note 14 — Earnings Per Share
  26. [26] Item 5, Operating and Financial Review — Consolidated Results of Operations
  27. [27] Item 5, Operating and Financial Review — Consolidated Results of Operations
  28. [28] Item 5, Operating and Financial Review — Key Financial Ratios
  29. [29] Item 5, Operating and Financial Review — Key Financial Ratios
  30. [30] Item 5, Operating and Financial Review — Liquidity and Capital Resources
  31. [31] Item 5, Operating and Financial Review — Liquidity and Capital Resources
  32. [32] Item 5, Operating and Financial Review — Financial Position
  33. [33] Item 5, Operating and Financial Review — Financial Position
  34. [34] Item 5, Operating and Financial Review — Lines of Business
  35. [35] Item 5, Operating and Financial Review — Lines of Business
  36. [36] Item 5, Operating and Financial Review — Lines of Business
  37. [37] Item 5, Operating and Financial Review — Lines of Business

Analysis on 9/27/2026